Cancer survival figures are misleading
2 Survival is a perfectly valid measure for comparisons within randomised control trials but is misleading for comparisons across time and place. 3 The apparent increases in survival since 1971 are, unfortunately, unlikely to be the result of improvements in cancer treatment alone as the article see...
Gespeichert in:
Veröffentlicht in: | BMJ (Online) 2014-05, Vol.348 (may19 15), p.g3315-g3315 |
---|---|
1. Verfasser: | |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
Zusammenfassung: | 2 Survival is a perfectly valid measure for comparisons within randomised control trials but is misleading for comparisons across time and place. 3 The apparent increases in survival since 1971 are, unfortunately, unlikely to be the result of improvements in cancer treatment alone as the article seems to claim.(29 April.) 2 Wegwarth O, Schwartz LM, Woloshin S, Gaissmaier W, Gigerenzer G. Do physicians understand cancer screening statistics? A national survey of primary care physicians in the United States. |
---|---|
ISSN: | 0959-8138 1756-1833 1756-1833 |
DOI: | 10.1136/bmj.g3315 |